TSPAN6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.018600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.396800E-01
Normal-vs-Stage2
6.320400E-01
Normal-vs-Stage3
3.841400E-01
Normal-vs-Stage4
5.813400E-01
Stage1-vs-Stage2
9.067800E-01
Stage1-vs-Stage3
4.856800E-01
Stage1-vs-Stage4
9.650400E-01
Stage2-vs-Stage3
5.069200E-01
Stage2-vs-Stage4
9.627400E-01
Stage3-vs-Stage4
4.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.974800E-01
Normal-vs-AfricanAmerican
6.528400E-01
Normal-vs-Asian
3.443200E-01
Caucasian-vs-AfricanAmerican
4.588200E-01
Caucasian-vs-Asian
8.642800E-01
AfricanAmerican-vs-Asian
4.312800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.865400E-01
Normal-vs-Female
3.001400E-01
Male-vs-Female
5.835800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.061600E-01
Normal-vs-Age(41-60Yrs)
5.654400E-01
Normal-vs-Age(61-80Yrs)
5.427400E-01
Normal-vs-Age(81-100Yrs)
5.456000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.032400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.013400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.862600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.297800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.051800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.951200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.520400E-01
Normal-vs-Daily Drinker
2.018200E-01
Normal-vs-Weekly Drinker
4.911200E-01
Normal-vs-Occasional Drinker
7.661600E-01
Normal-vs-Social Drinker
4.986400E-01
Non Drinker-vs-Daily Drinker
3.491200E-01
Non Drinker-vs-Weekly Drinker
1.863430E-01
Non Drinker-vs-Occasional Drinker
3.198600E-01
Non Drinker-vs-Social Drinker
3.130200E-01
Daily Drinker-vs-Weekly Drinker
8.595200E-01
Daily Drinker-vs-Occasional Drinker
1.088630E-01
Daily Drinker-vs-Social Drinker
9.147000E-01
Weekly Drinker-vs-Occasional Drinker
7.518100E-02
Weekly Drinker-vs-Social Drinker
9.574000E-01
Occasional Drinker-vs-Social Drinker
9.633800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.555000E-01
Normal-vs-Grade 2
3.644400E-01
Normal-vs-Grade 3
1.990760E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.538400E-01
Grade 1-vs-Grade 3
3.596300E-03
Grade 1-vs-Grade 4
7.555000E-01
Grade 2-vs-Grade 3
4.916800E-03
Grade 2-vs-Grade 4
3.644400E-01
Grade 3-vs-Grade 4
1.990760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.547600E-01
Normal-vs-NonDiabetic
2.319800E-01
Diabetic-vs-NonDiabetic
7.344200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.444600E-01
Normal-vs-NoPancreatitis
2.132600E-01
Pancreatitis-vs-NoPancreatitis
6.456000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.518800E-01
Normal-vs-N1
6.421400E-01
N0-vs-N1
2.398000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.842800E-01
Normal-vs-TP53-NonMutant
4.785400E-01
TP53-Mutant-vs-TP53-NonMutant
3.838600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
